Nektar Therapeutics (NASDAQ:NKTR): "I think it's a great spec. It's got a big pipeline of drugs. You know, look, the speculative stocks aren't working that well right now, but I don't want to sell the stock here. I think that would be a big mistake."
Align Technology (NASDAQ:ALGN): It's a good stock but is just few points off its highs. Let it cool down and buy at $335-340 in stages.
READ FULL ARTICLE HERE
MG+M The Law Firm (MG+M) is pleased to announce that it has elevated attorneys Stephanie M. Chesney
Burns & Levinson announced today that well-known plaintiff employment litigator Beth R. Myers has joined the firm
BayCoast Bank is delighted to announce Nicole Almeida as Senior Vice President, Chief Diversity Officer (CDO)
BayCoast Bank is pleased to announce Robert Bergdoll of Attleboro, Massachusetts, as First Vice President Marketing Director
For partnerships, content marketing or advertising inquiries, please contact Edwin through his LinkedIn Profile
Connect© Copyright 2024 citybuzz
